Detalhe da pesquisa
1.
Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies.
CA Cancer J Clin
; 72(2): 165-182, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34767258
2.
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
Cell
; 158(5): 1110-1122, 2014 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25171411
3.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
N Engl J Med
; 390(12): 1080-1091, 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38507751
4.
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Lancet Oncol
; 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38710187
5.
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 402(10411): 1423-1433, 2023 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37633306
6.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 384(16): 1529-1541, 2021 04 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33882206
7.
Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).
Breast Cancer Res Treat
; 2024 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38355821
8.
A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative).
Future Oncol
; 20(11): 635-651, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38270051
9.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37387213
10.
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Lancet Oncol
; 24(9): 1029-1041, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37657462
11.
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Breast Cancer Res
; 25(1): 112, 2023 10 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37784176
12.
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERß and Mutant p53.
Oncologist
; 28(4): 358-363, 2023 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36772966
13.
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.
Oncologist
; 28(2): 172-179, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36493359
14.
Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study).
Breast Cancer Res Treat
; 199(3): 501-509, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37103597
15.
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer.
Breast Cancer Res Treat
; 197(2): 319-331, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36401732
16.
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Breast Cancer Res Treat
; 201(1): 43-56, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37318638
17.
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Br J Cancer
; 126(3): 514-520, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34480094
18.
Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan.
Oncologist
; 27(8): 637-645, 2022 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35642907
19.
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
Oncologist
; 27(11): 930-939, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35852437
20.
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med
; 381(4): 307-316, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31166679